common.study.topics.clinical

Pharmacokinetics of Neostigmine and Glycopyrrolate

common.study.values.description

Pharmacokinetics of Neostigmine and Glycopyrrolate

A group of 6 able-bodied healthy volunteers will receive Neostigmine (NEO) and Glycopyrrolate (GLY) intravenously and via 3 different methods of Iontophoresis (ION) with subsequent blood draws over 1 hour in order to measure the pharmacokinetic behavior of the drugs en-vivo.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Combination of Neostigmine and Glycopyrrolate

Intravenous or transdermal

Device - I-Box by Dynatronics

Electric field conducting drugs through the skin without compromising its integrity

participant.views.study.view.additional

participant.views.study.view.scientific-title

Pharmacokinetics of Neostigmine and Glycopyrrolate After Intravenous and Transcutaneous Administration by Iontophoresis

common.study.values.clinical-trial-id

NCT04027972

participant.views.study.view.id

eZ6xwe